ANIK logo

ANIK

Anika Therapeutics Inc.

$9.38
+$0.15(+1.63%)
55
Overall
60
Value
50
Tech
--
Quality
Market Cap
$134.52M
Volume
194.59K
52W Range
$7.87 - $26.00
Target Price
$18.33
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$93.0M$103.4M$113.4M$105.6M$114.6M$130.5M$147.8M$156.2M$120.8M$119.9M
Total Revenue
$87.7M$102.9M$113.4M$105.6M$114.6M$130.5M$147.8M$156.2M$120.8M$119.9M
COST OF GOODS SOLD
Cost of Revenue
$-21.1M$-24.0M$-27.4M$-31.3M$28.7M$61.4M$64.9M$62.7M$38.3M$43.9M
GROSS PROFIT
Gross Profit
$71.9M$79.4M$86.1M$74.3M$85.9M$69.0M$82.9M$93.6M$82.5M$76.0M
OPERATING EXPENSES
Operating Expenses
$23.8M$28.7M$40.3M$52.5M$51.6M$83.5M$101.4M$113.0M$81.7M$81.1M
Research & Development
$9.0M$10.7M$18.8M$18.2M$16.7M$23.4M$27.3M$28.2M$21.8M$25.5M
Research Expense
$9.0M$10.7M$18.8M$18.2M$16.7M$23.4M$27.3M$28.2M$21.8M$25.5M
Selling, General & Administrative
$14.8M$18.0M$21.5M$34.3M$35.0M$60.1M$74.1M$84.8M$59.9M$55.6M
Selling & Marketing Expenses
$14.8M$18.0M$21.5M$34.3M------------
General & Administrative Expenses
$-1.3M$-1.3M$-1.8M$-1.8M$35.0M$60.1M$74.1M$84.8M$59.9M$55.6M
Salaries & Wages
$-2.2M$-3.4M$-5.8M$-11.0M$-100.0K$-200.0K$-100.0K------
Depreciation & Amortization
$-2.7M$-2.7M$-3.3M$-4.9M$5.0M$6.1M$6.5M$6.7M$6.4M$6.9M
Depreciation & Amortization
$-2.7M$-2.7M$-3.3M$-4.9M$5.0M$6.1M$6.5M------
Amortization
$-1.1M$-1.1M$-1.0M$-1.0M$7.7M$91.3M$82.5M$74.7M$9.8M$9.3M
Other Operating Expenses
$-38.0K$-52.0K$-1.6M$-57.0K$2.3M--$3.0M------
OPERATING INCOME
Operating income
$48.1M$50.6M$45.7M$21.7M$34.2M$-28.3M$2.6M$-19.4M$844.0K$-5.1M
EBITDA
$52.0M$54.6M$50.5M$29.1M$43.3M$-1.0M$-4.2M$-2.4M$15.1M$3.0M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
----------$25.0K$19.0K------
Intinc
$120.0K$263.0K$473.0K$1.5M$1.9M$-302.0K$-188.0K$654.0K$2.3M$2.3M
Net Non-Operating Interest Income/Expense
$120.0K$263.0K$473.0K$1.5M$1.9M$-302.0K$-188.0K$654.0K$2.3M$2.3M
Other Income/Expense
$-3.0K$-16.0K$-906.0K$-360.0K$-158.2M$-28.7M$-21.1M$-180.0K$-105.0K$-65.0K
Other Special Charges
----$900.0K--------------
SPECIAL ITEMS
Restructring And Mn A Income
--------$-7.1M$23.0M--------
Special Income Charges
--------$7.1M$-42.5M----$-62.2M$-2.5M
Impairment of Capital Assets
--------$389.0K$42.5M----$62.2M--
PRE-TAX INCOME
EBIT
$48.3M$50.9M$46.2M$23.2M$36.1M$-14.5M$-18.5M$-18.7M$844.0K$-5.1M
Pre-Tax Income
$48.3M$50.9M$46.2M$23.2M$36.1M$-28.6M$2.4M$-18.7M$3.2M$-2.8M
INCOME TAX
Tax Provision
$17.5M$18.3M$14.4M$4.5M$8.9M$-4.6M$-1.7M$-3.9M$6.6M$6.1M
NET INCOME
Net Income
$30.8M$32.5M$31.8M$18.7M$27.2M$-24.0M$4.1M$-14.9M$-82.7M$-56.4M
Net Income (Continuing Operations)
$30.8M$32.5M$31.8M$18.7M$27.2M$-24.0M$4.1M$-14.9M$-3.4M$-8.8M
Net Income (Discontinued Operations)
$30.8M$32.5M$31.8M$18.7M$27.2M$-24.0M$4.1M$-14.9M$-82.7M$-56.4M
Net Income (Common Stockholders)
$30.8M$32.5M$31.8M$18.7M$27.2M$-24.0M$4.1M$-14.9M$-82.7M$-56.4M
TOTALS
Total Expenses
$2.8M$4.7M$13.0M$21.2M$80.4M$144.9M$166.3M$175.6M$119.9M$125.0M
SHARE & EPS DATA
Average Shares Outstanding
$14.9M$14.7M$14.6M$14.4M$14.1M$14.2M$14.4M$14.6M$14.7M$14.7M
Average Shares Outstanding (Diluted)
$15.3M$15.1M$15.1M$14.7M$14.4M$14.2M$14.6M$14.6M$14.7M$14.7M
Shares Outstanding
$14.3M$14.6M$14.7M$14.2M$14.2M$14.3M$14.5M$14.6M$14.8M$14.2M
Basic EPS
$2.06$2.22$2.18$1.3$1.93$-1.69$0.29$-1.02$-5.64$-3.83
Basic EPS (Continuing Operations)
--------$1.93$-1.69$0.29$-1.02$-5.64$-0.60
Diluted EPS
$2.01$2.15$2.11$1.27$1.89$-1.69$0.28$-1.02$-5.64$-3.83
Diluted EPS (Continuing Operations)
--------$1.89$-1.69$0.28$-1.02$-5.64$-0.60
OTHER METRICS
Basic Discontinuous Operations
------------------$-3.23
Diluted Discontinuous Operations
------------------$-3.23
Net Income Discontinuous Operations
----$9.8M----------$-79.2M$-47.6M
Other Gand A
$-1.3M$-1.3M$-1.8M$-1.8M$35.0M$60.1M$74.1M$84.8M$59.9M$55.6M
Other Impairment Of Capital Assets
$-697.0K------------------
Other Write Off
$-3.0K$-16.0K$-6.0K$-360.0K$-505.0K$-86.0K$-92.0K------
Provision For Gain Loss On Disposal
----$9.8M--------------
Rent And Landing Fees
$-1.3M$-1.3M$-1.8M$-1.8M------------
Selling Expense
$14.8M$18.0M$21.5M$34.3M------------
Restruct
--------$-7.1M$23.0M--------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2ANIK$9.38+1.6%194.59K
3
4
5
6

Get Anika Therapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.